<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00460538</url>
  </required_header>
  <id_info>
    <org_study_id>MIL-002</org_study_id>
    <nct_id>NCT00460538</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms</brief_title>
  <official_title>Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milsing d.o.o.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milsing d.o.o.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine weather Lectranal is effective in treatment of
      seasonal allergic rhinitis symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients allergic to the specific pollen are divided into two groups randomly. One group is
      being administered Lectranal and the other group is being administered placebo during the
      period of 6 weeks in season of the pollen. Methods used for evaluation are: SARS
      questionnaire(seasonal allergic rhinitis symptoms), Mini RQLQ (mini rhinoconjunctivitis
      quality of life questionnaire) skin Prick test, specific IgE and IgG, eosinophilia in nasal
      secretion. Methods used for follow up safety include side effects report, physical
      examination and vital signs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in SARS (seasonal allergic rhinitis symptoms)</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire)</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in specific IgE</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in specific IgG</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prick test change</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in eosinophilia in nasal secretion</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Seasonal Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lectranal</intervention_name>
    <description>Dosage form: capsule
1: Dosage: 2 capsule Frequency and duration: 2 times daily over the 6 weeks</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Dosage form: capsule 2: Dosage: 2 capsules Frequency and duration: 2 times daily over the 6 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  history of seasonal allergic rhinitis symptoms to pollen

          -  positive skin prick test to pollen

          -  negative history of seasonal allergic asthma

          -  male or female older than 18

          -  female participants must use appropriate contraception

          -  able to comply to study procedures

        Exclusion Criteria:

          -  pregnancy

          -  alcohol or drug abuse

          -  subject receiving antihistamines , immunotherapy or on hyposensibilisation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neven Tudoric, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dubrava University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dubrava University Hospital</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <results_reference>
    <citation>Matkovic Z, Zivkovic V, Korica M, Plavec D, Pecanic S, Tudoric N. Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis. Phytother Res. 2010 Feb;24(2):175-81. doi: 10.1002/ptr.2877.</citation>
    <PMID>19504468</PMID>
  </results_reference>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2007</study_first_submitted>
  <study_first_submitted_qc>April 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2007</study_first_posted>
  <last_update_submitted>April 2, 2010</last_update_submitted>
  <last_update_submitted_qc>April 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Neven Tudoric MD PhD</name_title>
    <organization>Dubrava University Hospital, Zagreb, Croatia</organization>
  </responsible_party>
  <keyword>Seasonal allergic rhinitis</keyword>
  <keyword>lectranal</keyword>
  <keyword>allergy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

